Remegen Co., Ltd.

This phase 3 trial tests whether telitacicept can slow kidney function loss in 318 adults with IgA nephropathy who are at risk of kidney failure despite standard care. Participants receive either the drug or a placebo, and researchers measure changes in urine protein and kidney f…

This early-stage trial tests an experimental drug called RC148, given alone or with other treatments, for people with advanced non-small cell lung cancer that has spread. The study involves 121 participants and aims to see if the drug shrinks tumors and how safe it is. It is for …

This study tests a new drug combination for people with advanced stomach cancer that has spread. It includes an antibody-drug conjugate (RC48-ADC) plus immunotherapy (toripalimab) and either chemotherapy or another targeted drug (trastuzumab). The goal is to see if these combos c…